NVIDIA dispara Wall Street… pero hoy la FED puede cambiarlo TODO
7 extracted signals · 6 resolved · 1 still active
Jon EconomistIndependent analyst profile- Source published
- 28 Aug 2026, 06:47 UTC
- Recorded by Tahlil Plus
- 28 Aug 2026, 08:35 UTC

AI-generated source summary
The analysis covers several US tech stocks and the cryptocurrency market. NVDA is showing strength, breaking out of a range and potentially targeting new highs near $235, with support at $219. CRM and CRWD are also exhibiting bullish sentiment, with CRM targeting $270 and CRWD potentially retesting previous highs around $235. MRVL's recent dip to $241.45 after strong earnings might present a buying opportunity, targeting a continuation of the uptrend if it holds above $235. PYPL is facing resistance and a potential breakdown below $61.47, with a bearish outlook targeting $57 and a failure bound at $63. Bitcoin, at $79,800, is showing a bullish trend, potentially targeting $82,000, with invalidation below $78,000. The overall market sentiment is mixed, with some sectors showing strength while others face headwinds.
AI-generated summary based on the source content.
Signal outcomes at a glance
Partially ResolvedSignals in this source







Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
7 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Live evaluation in progress
1 signal remains active.
Jon Economist
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.